“…Additionally, when treated with Ca 2+ and A23187, human erythrocytes and lymphocytes respond by budding to release membrane vesicles (Allan and Michell, 1975;Allan et al, 1976a;PodszywalowBartnicka et al, 2007). This treatment also induces several other biochemical changes, including K + efflux (Lew and Ferreira, 1976;Dupuis et al, 1989), the breakdown of polyphosphoinositides, a rise in 1,2-diacylglycerol and phosphatidate concentrations (Allan et al, 1976b;Allan and Michell, 1978;Ponnappa et al, 1980;Allan and Thomas, 1981;Butikofer et al, 1993), and a selective loss of glycosylphosphatidylinositol-anchored membrane proteins (Butikofer et al, 1993). The treatment of hematopoietic cells with A23187 can thus be regarded as a model with which to investigate the biochemical mechanisms responsible for membrane composition during intracellular calcium elevation.…”